MISSION® esiRNA
SIGMA/EHU080431 - targeting human NCL
Product Type: Product-on-demand
| description | Powered by Eupheria Biotech |
| Ensembl | human accession no. | ENSG00000115053 ![]() |
| esiRNA cDNA target sequence | GGGCGATCTATTTCCCTGTACTATA |
| form | lyophilized powder |
| NCBI accession no. | NM_005381 ![]() |
| product line | MISSION® |
| Quality Level | 100 ![]() |
| shipped in | ambient |
| storage temp. | −20°C |
| Application: | MISSION® esiRNA has been used for transfection of cells to target nucleolin. |
| Biochem/physiol Actions: | NCL (nucleolin) is ribonucleoprotein, mainly involved in ribosomal biogenesis. Additionally, it is linked with cell differentiation and proliferation, stress-conditioned responses and cellular shuttling. This gene is upregulated in cancer cells. In cancer cells, it is associated with progression and is mainly present on the membrane of cancer cells. On the membrane, it binds to tumor promoting proteins. |
| General description: | MISSION® esiRNA are endoribonuclease prepared siRNA. They are a heterogeneous mixture of siRNA that all target the same mRNA sequence. These multiple silencing triggers lead to highly-specific and effective gene silencing. For additional details as well as to view all available esiRNA options, please visit SigmaAldrich.com/esiRNA . |
| Legal Information: | MISSION is a registered trademark of Merck KGaA, Darmstadt, Germany |
| RIDADR | NONH for all modes of transport |
| Flash Point(F) | Not applicable |
| Flash Point(C) | Not applicable |
| Storage Temp. | −20°C |
| UNSPSC | 41105324 |

